# OnCo record transthera (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/transthera/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "transthera" ;
  schema:name "TransThera Sciences"@en ;
  schema:description "Chinese biotech running the first phase 3 of a next-generation FGFR inhibitor, tinengotinib, for bile duct cancer that has stopped responding to first-generation FGFR drugs."@en ;
  schema:url <https://onco.cc/companies/transthera/>, <https://www.transtherabio.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.transtherabio.com> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/tinengotinib/> ;
  onco:trials <https://onco.cc/trials/nct07498478/>, <https://onco.cc/trials/nct05948475/> .